Atrinsic (NASDAQ:PTIX), Inc. (NASDAQ: PTIX) is a digital health company specializing in remote monitoring solutions for cardiorespiratory assessment. Leveraging its proprietary sensor technology and cloud‐based analytics platform, Atrinsic enables healthcare providers to collect, analyze and act upon patient data both inside and outside the clinical setting. The company’s core offerings include wearable and bedside monitoring devices that capture vital signs and respiratory parameters, along with a software suite that supports real‐time alerts, longitudinal trend tracking and clinical decision support.
The company’s product portfolio features FDA‐cleared monitoring systems designed for use in hospitals, outpatient clinics and patients’ homes. Atrinsic’s sensors measure metrics such as respiratory rate, tidal volume and heart rate variability, transmitting data securely to healthcare teams via its HIPAA‐compliant cloud infrastructure. By integrating seamlessly with electronic health records and telehealth platforms, the Atrinsic solution streamlines workflows for physicians, respiratory therapists and nursing staff, helping to reduce hospital readmissions and improve patient outcomes.
Founded in the late 1970s as eResearch Technology, the company has built a multi‐decade track record in biomedical research and clinical monitoring. Headquartered in Newton, Massachusetts, Atrinsic rebranded under its current name in early 2024 to reflect its broader focus on digitally enabled patient care. Over the years, the company has expanded its reach to healthcare institutions and life science organizations across North America, Europe and the Asia‐Pacific region, supporting clinical trials, post‐market surveillance studies and chronic disease management programs.
Atrinsic is led by Chief Executive Officer Robert Montemayor, whose background spans medical device commercialization and digital health innovation, and Chief Financial Officer Sarah Liu, with extensive experience in public company financial management. The management team also includes leaders in regulatory affairs, product development and global sales, all working together to advance Atrinsic’s mission of delivering actionable insights that empower providers to deliver more effective, patient‐centric care.
